Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia

被引:0
作者
Alberto Lopez-Clavijo, Carlos [1 ,2 ,3 ,4 ]
Esteban Gaviria-Maya, Juan [5 ]
Eduardo Henao-Florez, Rodrigo [2 ]
Leandro Piedrahita-Gutierrez, Dany [3 ,6 ]
机构
[1] InSer Pereira, Pereira, Colombia
[2] Univ Caldas, Ginecol & Obstet, Manizales, Colombia
[3] Fdn Univ Autonoma Amer, Medellin, Colombia
[4] Univ Tecnol Pereira, Biol Mol & Biotecnol, Pereira, Colombia
[5] Univ Caldas, Manizales, Colombia
[6] InSer Pereira, Endocrinol Reprod Humana & Infertilidad, Pereira, Colombia
关键词
Amenorrhea; Galactorrhea; Hyperprolactinemia; Infertility; Magnetic Resonance Imaging; Prolactin; Prolactinoma;
D O I
10.17533/udea.iatreia.v29n3a04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic resonance (MR), between January 2008 and July 2013. Clinical manifestations, etiology, serum prolactin level, and MR findings were included. Results: The most frequent clinical manifestations were: infertility, galactorrhea, oligomenorrhea. There were 26 cases of prolactinoma (57.8 %), and 12 of idiopathic hyperprolactinemia (26.6 %). Out of the 26 prolactinomas, 23 were microadenomas (average size 5.1 mm; SD +/- 3.2 mm). Average serum prolactin level was 74.05 ng/mL (SD +/- 13.33 ng/mL). 78 % of patients with prolactinoma had serum prolactin level under 70.0 ng/mL. No significant association was found between serum prolactin level and the presence of prolactinoma. Conclusion: Prolactinomas are the main cause of hyperprolactinemia and they are found mostly with slight rise of serum prolactin. Pituitary MRI is recommended in patients with hyperprolactinemia, regardless of their prolactin level.
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [11] Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment
    Raven, Lisa M.
    Guttman-Jones, Michelle
    Muir, Christopher A.
    ENDOCRINE, 2021, 72 (02) : 524 - 528
  • [12] Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment
    Lisa M. Raven
    Michelle Guttman-Jones
    Christopher A. Muir
    Endocrine, 2021, 72 : 524 - 528
  • [13] Nutritional and metabolic assessment in overweight patients with and without hyperprolactinemia caused by prolactinoma
    de Freitas, Bruna Breyer
    Rothen, Renata Elisabeth
    Zeni, Debora
    Soares Leaes, Carolina Garcia
    Oliveira, Miriam da Costa
    Busnello, Fernanda Michielin
    Semmelmann Pereira-Lima, Julia Fernando
    NUTRICION HOSPITALARIA, 2015, 32 (05) : 2030 - 2037
  • [14] Pregnancy and Tumor Outcomes in Women with Prolactinoma: Prolactinoma and Pregnancy: Outcomes
    Araujo, Barbara
    Belo, Sandra
    Carvalho, Davide
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (10) : 642 - 648
  • [15] Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up
    Radavelli-Bagatini, Simone
    Lhullier, Francisco L. R.
    Mallmann, Elaine S.
    Spritzer, Poli Mara
    NEUROENDOCRINOLOGY LETTERS, 2013, 34 (03) : 207 - 211
  • [16] Hemoglobin decline as a signal for hyperprolactinemia onset prior to prolactinoma diagnosis in hypogonadal men
    Rudman, Yaron
    Duskin-Bitan, Hadar
    Richter, Ilan
    Tsvetov, Gloria
    Masri-Iraqi, Hiba
    Akirov, Amit
    Shimon, Ilan
    ANDROLOGY, 2023, : 1398 - 1407
  • [17] Evaluation of Hyperandrogenemia in Women with Prolactinoma
    Unal, Mehmet Cagri
    Karaca, Zuleyha
    Unluhizarci, Kursad
    Kelestemur, Fahrettin
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 24 (01) : 55 - 62
  • [18] Clinical effectiveness of the various approaches for infertility treatment in women with PCOS and hyperprolactinemia
    Gladchuk IZ
    Semenyuta OM
    Onyshchenko YV
    中国现代医学杂志, 2014, (16) : 1 - 4
  • [19] The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients
    Huan, Cheng
    Cui, Guihua
    Ren, Zongming
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 28 (02) : 713 - 718
  • [20] Clinical and diagnostic characteristics of hyperprolactinemia in childhood and adolescence
    Catli, Gonul
    Abaci, Ayhan
    Bober, Ece
    Buyukgebiz, Atilla
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2013, 26 (1-2) : 1 - 11